Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ethical and legal issues in psychedelic harm reduction and integration therapy
Brian Pilecki, Jason B. Luoma, Geoff J. Bathje, et al.
Harm Reduction Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Case analysis of long-term negative psychological responses to psychedelics
Rebecka Bremler, Nancy Katati, Parvinder Shergill, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 44
Pattern breaking: a complex systems approach to psychedelic medicine
Inês Hipólito, Jonas Mago, Fernando E. Rosas, et al.
Neuroscience of Consciousness (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 39
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder
Joshua D. Rosenblat, M. Ishrat Husain, Yena Lee, et al.
The Canadian Journal of Psychiatry (2022) Vol. 68, Iss. 1, pp. 5-21
Open Access | Times Cited: 38
Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry
Gregory Barber, Charles C. Dike
Psychiatric Services (2023) Vol. 74, Iss. 8, pp. 838-846
Closed Access | Times Cited: 37
Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020
Emma I Kopra, Jason Ferris, Adam Winstock, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 733-748
Open Access | Times Cited: 34
The need for establishing best practices and gold standards in psychedelic medicine
Allison A. Feduccia, Gabby Agin-Liebes, Collin M. Price, et al.
Journal of Affective Disorders (2023) Vol. 332, pp. 47-54
Closed Access | Times Cited: 23
Counselors’ attitudes toward psychedelics and their use in therapy
Benjamin Hearn, Michael D. Brubaker, George B. Richardson
Journal of Counseling & Development (2022) Vol. 100, Iss. 4, pp. 364-373
Open Access | Times Cited: 33
Naturalistic Psychedelic Use: A World Apart from Clinical Care
Nicolas G. Glynos, Christopher W. Fields, Julie Barron, et al.
Journal of Psychoactive Drugs (2022) Vol. 55, Iss. 4, pp. 379-388
Closed Access | Times Cited: 31
Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines
Sean J. Belouin, Lynnette A. Averill, Jack E. Henningfield, et al.
Neuropharmacology (2022) Vol. 219, pp. 109214-109214
Open Access | Times Cited: 31
Psilocybin’s effects on cognition and creativity: A scoping review
Justin N Bonnieux, Baeleigh VanderZwaag, Zahra Premji, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 635-648
Open Access | Times Cited: 17
Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ)
Max Wolff, Ricarda Evens, Lea J. Mertens, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 5, pp. 432-457
Open Access | Times Cited: 7
New Paradigms of Old Psychedelics in Schizophrenia
Danish Mahmood, Sattam Khulaif Alenezi, Md Jamir Anwar, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 640-640
Open Access | Times Cited: 25
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research
David B. Yaden, Marianna Graziosi, Anna Owen, et al.
Psychedelic Medicine (2025)
Closed Access
Social Worker Attitudes towards Psychedelics
Eva Nowakowski-Sims, Joshua Holzworth
Clinical Social Work Journal (2025)
Open Access
Cultural Humility and Psychedelics: A Framework Analysis of Psychedelic-Assisted Therapy Manuals and Practice Guidelines
A. Bell, Bianca R. Watt, Arturo S. Lopez Flores, et al.
Research Square (Research Square) (2025)
Closed Access
Self-treatment with psychedelic substances for health and wellbeing in Aotearoa New Zealand: an exploratory descriptive study
Chris Arnison, Richard Egan, John H. Shaver
Kōtuitui New Zealand Journal of Social Sciences Online (2025), pp. 1-22
Open Access
Societal Trends and Opportunities in the Aftermath of the Nova Psychedelic Trance Rave, Through Lilla and Benjamin
Demian Halperin, Tal Bar On, Nir Tadmor, et al.
Future Humanities (2025) Vol. 3, Iss. 1
Open Access
Integration in Psychedelic-Assisted Treatments: Recurring Themes in Current Providers’ Definitions, Challenges, and Concerns
Mitch Earleywine, Fiona Low, Carmen Lau, et al.
Journal of Humanistic Psychology (2022)
Closed Access | Times Cited: 19
Predictors of Psychedelic Experience: A Thematic Analysis
Annie M. McCartney, H. T. McGovern, Alexander De Foe
Journal of Psychoactive Drugs (2022) Vol. 55, Iss. 4, pp. 411-419
Open Access | Times Cited: 19
Psilocybin in Palliative Care: An Update
Emily Whinkin, Moira Opalka, Conor Watters, et al.
Current Geriatrics Reports (2023) Vol. 12, Iss. 2, pp. 50-59
Open Access | Times Cited: 12
Psychologists' and psychotherapists' knowledge, attitudes, and clinical practices regarding the therapeutic use of psychedelics
Aileen Kucsera, Trisha Suppes, Nancy A. Haug
Clinical Psychology & Psychotherapy (2023) Vol. 30, Iss. 6, pp. 1369-1379
Open Access | Times Cited: 11
Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study
P. Todd Korthuis, Kim Hoffman, Adrianne R. Wilson‐Poe, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 8, pp. 761-768
Closed Access | Times Cited: 4
Are you tripping comfortably? Investigating the relationship between harm reduction and the psychedelic experience
Madelene Palmer, Olivia Maynard
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 18
Social identity processes as a vehicle for therapeutic success in psychedelic treatment
Martha Newson, S. Alexander Haslam, Catherine Haslam, et al.
Nature Mental Health (2024) Vol. 2, Iss. 9, pp. 1010-1017
Closed Access | Times Cited: 3
Focusing on the negative: cases of long-term negative psychological responses to psychedelics
Rebecka Bremler, Nancy Katati, Parvinder Shergill, et al.
(2023)
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top